Giuseppe Gaipa
0000-0002-1006-5946
209 papers found
Refreshing results…
Immunological changes in CD4+CD25+ circulating regulatory T cells (T-reg) after extracorporeal photochemotherapy: results of a prospective monitoring of 10 patients affected by GvHD after allogeneic HSCT
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease
Minimal residual disease detection in precursor B lymphoblastic leukemia using a single nine-color antibody panel and thirteen-parameter flow cytometry
Early evaluation of bone marrow minimal residual disease by flowcytometry on day 15 is feasible on a multicenter basis and bears strong prognostic value in childhood acute lymphoblastic leukemia. The AIEOP-BFM experience
Isolation of monocytes from leukapheresis products for large-scale GMP-grade generation of CMV-specific T-cell lines by means of an automated elutriation device (Elutra®)
Infusion of Donor Derived Cytokine Induced Killer Cells May Induce Clinical Remission with Limited GVHD in Patients Relapsing after Allogeneic Stem Cell Transplantation.
Purified Peripheral Autologous Stem Cell Transplant Versus Conventional Chemotherapy for Childhood Low Risk Relapsed Acute Lymphoblastic Leukemia.
Simultaneous application of flow cytometry and RQ-PCR in the detection of minimal residual disease in childhood acute lymphoblastic leukemia
Large-scale GMP-grade production of CMV-specific T-cell lines using CMV-specific peptides for clinical use
Monitoring of minimal residual disease in leukemia, advantages and pitfalls
Four pediatric acute biphenotypic leukemia cases: Diagnostic and therapeutic implications
CD34 + Stem Cell Recovery After Positive Selection of "Overloaded" Immunomagnetic Columns
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection
Role of molecular remission in autologous grafting for late or extramedullary relapse in childhood acute lymphoblastic leukaemia
Rituximab for prophylaxis of EBV reactivation following HCST in patients with inherited metabolic storage diseases
CD34+cells recovery after positive-selection performed with column over-loading
Reply to van der Sluijs-Gelling et al [11]
Reconstitution of lymphocyte subpopulations in children with lysosomal diseases after haematopoietic cell transplantation
Donor lymphocyte infusions for graft failure following hematopoietic stem cell transplantation for Hurler syndrome: A case report
Missing publications? Search for publications with a matching author name.